Products
Latest Partnered Companies
Projects
Estimated Cost :
€400 million
Sanofi to invest €400 million to Create a Unique Vaccine Production Site in Singapore
Sanofi announced a €400 million investment over five years to create a unique vaccine production
Estimated Cost :
$150 Million
KBI Biopharma Invests $150 Millionto Expand Commercial Manufacturing Facility in North California
KBI Biopharma, Inc, plans to open a new facility for commercial manufacturing. The manufacturing site involves an investment of US$150 million. The fa...
Estimated Cost :
$14 Million
Cascade Chemistry Plans for Expansion of cGMP Pharmaceutical Manufacturing Capacity
Cascade Chemistry invests $14 million for construction of new facilities designed to increase
Estimated Cost :
-
Bristol Myers Squibb to invest in New Cell Therapy Manufacturing facility in Massachusetts, USA
Construction is underway for a new cell therapy manufacturing facility in Devens, Mass., a part of Bristol Myers Squibb’s
Press Release
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform
Terumo Blood and Cell Technologies and CSL Plasma announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial of the investigational plasmapheresis device began earlier this month
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
MannKind Corporation and United Therapeutics reached a milestone in the development of Tyvaso DPI™ as United Therapeutics submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA).
Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of complex biologics and bioconjugates has announced that the location of its new GMP manufacturing facility will be Sanford, North Carolina. The significant expansion of Abzena’s capacity is driven by an increase in customer demand
Lyndra Therapeutics Presents Promising Phase 2 Data on Once-Weekly Oral Risperidone Treatment, LYN-005, in Development for Schizophrenia
Lyndra Therapeutics, a clinical-stage biotechnology company working to make daily pills a thing of the past, announced results from its Phase 2 study of LYN-005, the Company’s oral, ultra-long-acting, extended-release (ER) risperidone capsule
Events
Triple Negative Breast Cancer (TNBC) Drug Development Digital Summit 2021
Articles
Top 12 Analytical Lab Equipments in Pharmaceutical Industry
The analytical lab equipments or instruments are used in analytical applications in pharmaceutical, food-processing laboratories
A Complete Guide on Blister Packaging Machine
Packaging machinery is one of the vital equipment in the pharmaceutical industry, food processing, and chemical
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Focus on drug discovery and development has shifted away from small to large, complex molecular entities
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Advertisements
See your banner here...
.jpg)
Thank you for contacting us. One of our support staff will get in touch with you shortly.
Happy Surfing!
Regards,
Client Success Team (CRM),
